Literature DB >> 5782109

Rifampicin inhibits the growth of some mammalian viruses.

J H Subak-Sharpe, M C Timbury, J F Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5782109     DOI： 10.1038/222341a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  47 in total

Review 1.  The contribution of virology to contemporary medicine.

Authors:  C Stuart-Harris
Journal:  Br J Prev Soc Med       Date:  1975-03

2.  Antiviral action of a rifamycin derivative: formation Rous sarcoma virus particles deficient in 60 to 70S RNA.

Authors:  C Szabo; M J Bissell
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

3.  Investigating Viruses during the Transformation of Molecular Biology.

Authors:  Bernard Moss
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

4.  Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin.

Authors:  Damià Garriga; Stephen Headey; Cathy Accurso; Menachem Gunzburg; Martin Scanlon; Fasséli Coulibaly
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-01       Impact factor: 11.205

5.  Failure of rifampin to inhibit frog polyhedral cytoplasmic deoxyribovirus multiplication.

Authors:  L S Kucera
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

6.  Inhibition of a vesicular stomatitis virus mutant by rifampin.

Authors:  M C Moreau
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

7.  The inhibition of variola minor virus multiplication by rifampicin.

Authors:  T H Pennington
Journal:  Arch Gesamte Virusforsch       Date:  1970

8.  Effect of rifamycins and related antibiotics on the deoxyribonucleic acid-dependent ribonucleic acid polymerase of vaccinia virus particles.

Authors:  J F Szilágyi; T H Pennington
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

9.  Inhibition of infectious Rous sarcoma virus production by rifamycin derivative.

Authors:  C Szabo; M J Bissell; M Calvin
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

10.  Enhancement of activity against influenza viruses by combinations of antiviral agents.

Authors:  F G Hayden; R G Douglas; R Simons
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.